British Columbia Extends Biosimilar Switching To Adalimumab

Follows Launch Of Five Humira Biosimilars In Canada In February

 
• By David Wallace
  
British Columbia Canada Flags
British Columbia is flying the flag for biosimilar switching in Canada • Source: Alamy

More from Biosimilars

More from Products